ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
ANI Pharmaceuticals (NASDAQ: ANIP) has announced its participation in the upcoming H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ. The company's presentation is scheduled for Tuesday, May 20, 2025, at 1:30pm ET. CEO Nikhil Lalwani and CFO Stephen Carey will represent the company at the conference.
Investors can access the presentation through a live webcast on ANI's website under the Investors section. The webcast recording will remain available for 90 days after the event. One-on-one meetings with management can be arranged through meetings@hcwco.com.
ANI Pharmaceuticals (NASDAQ: ANIP) ha annunciato la sua partecipazione al prossimo H.C. Wainwright 3rd Annual BioConnect Investor Conference presso il NASDAQ. La presentazione dell'azienda è programmata per martedì 20 maggio 2025, alle 13:30 ET. Il CEO Nikhil Lalwani e il CFO Stephen Carey rappresenteranno la società durante la conferenza.
Gli investitori potranno seguire la presentazione tramite una diretta streaming disponibile nella sezione Investitori del sito web di ANI. La registrazione del webcast resterà accessibile per 90 giorni dopo l'evento. È possibile organizzare incontri individuali con il management scrivendo a meetings@hcwco.com.
ANI Pharmaceuticals (NASDAQ: ANIP) ha anunciado su participación en la próxima 3ª Conferencia Anual de Inversores BioConnect de H.C. Wainwright en NASDAQ. La presentación de la compañía está programada para el martes 20 de mayo de 2025 a la 1:30 pm ET. El CEO Nikhil Lalwani y el CFO Stephen Carey representarán a la empresa en la conferencia.
Los inversores pueden acceder a la presentación a través de una transmisión en vivo en el sitio web de ANI en la sección de Inversores. La grabación del webcast estará disponible durante 90 días después del evento. Se pueden concertar reuniones individuales con la dirección escribiendo a meetings@hcwco.com.
ANI Pharmaceuticals (NASDAQ: ANIP)가 다가오는 H.C. Wainwright 제3회 연례 BioConnect 투자자 컨퍼런스에 NASDAQ에서 참여할 것이라고 발표했습니다. 회사의 발표는 2025년 5월 20일 화요일 오후 1시 30분 ET에 예정되어 있습니다. CEO 니킬 랄와니와 CFO 스티븐 케리가 컨퍼런스에서 회사를 대표합니다.
투자자들은 ANI 웹사이트의 투자자 섹션에서 라이브 웹캐스트를 통해 발표를 시청할 수 있습니다. 웹캐스트 녹화는 행사 후 90일 동안 제공됩니다. 경영진과의 1:1 미팅은 meetings@hcwco.com으로 연락하여 예약할 수 있습니다.
ANI Pharmaceuticals (NASDAQ : ANIP) a annoncé sa participation à la prochaine 3e conférence annuelle BioConnect pour investisseurs de H.C. Wainwright au NASDAQ. La présentation de la société est prévue pour le mardi 20 mai 2025 à 13h30 ET. Le PDG Nikhil Lalwani et le directeur financier Stephen Carey représenteront l’entreprise lors de la conférence.
Les investisseurs peuvent accéder à la présentation via une diffusion en direct sur le site Web d’ANI, dans la section Investisseurs. L’enregistrement du webcast restera disponible pendant 90 jours après l’événement. Des réunions individuelles avec la direction peuvent être organisées en contactant meetings@hcwco.com.
ANI Pharmaceuticals (NASDAQ: ANIP) hat seine Teilnahme an der bevorstehenden 3. jährlichen BioConnect Investorenkonferenz von H.C. Wainwright am NASDAQ angekündigt. Die Präsentation des Unternehmens ist für Dienstag, den 20. Mai 2025, um 13:30 Uhr ET geplant. CEO Nikhil Lalwani und CFO Stephen Carey werden das Unternehmen auf der Konferenz vertreten.
Investoren können die Präsentation über einen Live-Webcast auf der Website von ANI im Bereich Investoren verfolgen. Die Aufzeichnung des Webcasts wird 90 Tage nach der Veranstaltung verfügbar sein. Einzelgespräche mit dem Management können über meetings@hcwco.com arrangiert werden.
- None.
- None.
PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ as follows:
| Date: | Tuesday, May 20, 2025 |
| Time: | 1:30pm ET |
| Webcast: | Click Here |
To schedule a 1x1 meeting with management, please contact meetings@hcwco.com.
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) presenting at the H.C. Wainwright BioConnect Conference 2025?
Who will be presenting for ANI Pharmaceuticals at the H.C. Wainwright Conference?
How can investors access ANI Pharmaceuticals' presentation at the BioConnect Conference?
How long will the replay of ANI Pharmaceuticals' BioConnect Conference presentation be available?
